LUKE M. BESHAR

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Mary Grendell, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LUKE M. BESHAR:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 24,000 12 Jun 2025 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 18,118 07 Jun 2023 Direct
REGENXBIO Inc. Director Stock Option (Right to Buy) 10,000 04 Jun 2021 Direct
Trillium Therapeutics Inc. Director Deferred Share Unit 0 17 Nov 2021 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by LUKE M. BESHAR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARA Protara Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:05
TARA Protara Therapeutics, Inc. 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 18:00
OMGA Omega Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
TARA Protara Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:10
TARA Protara Therapeutics, Inc. 30 Jun 2022 1 +$31,000 4 Director 05 Jul 2022, 17:00
OMGA Omega Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:10
TARA Protara Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 09 Jun 2022, 16:10
TARA Protara Therapeutics, Inc. 14 Mar 2022 1 +$42,500 4 Director 16 Mar 2022, 16:37
TARA Protara Therapeutics, Inc. 10 Mar 2022 1 +$44,555 4 Director 14 Mar 2022, 16:37
TRIL Trillium Therapeutics Inc. 17 Nov 2021 3 $0 4 Director 19 Nov 2021, 12:30
OMGA Omega Therapeutics, Inc. 29 Jul 2021 1 $0 4 Director 30 Jul 2021, 17:05
OMGA Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 21:00
TARA Protara Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 20:01
RGNX REGENXBIO Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:15